PG The Procter & Gamble Company

PG The Procter & Gamble Company

Consumer Defensive · Household & Personal Products

Market read

POC $144.04 · VWAP $146.58 · -2.4% vs 12m avg buyer

basing vol: normalchurn: quiet as of

Insiders no data — outside the Form 4 poll — US-filer feed only (foreign filers report via MAR managers'-transactions notices)

Coverage

2 watchlists

PG Price Structure

Loading chart…

Loading timeframes…

Peers

Every watchlist PG belongs to, members best 30-day change first — PG highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.

Desk commentary

Authored analysis and challenge notes tied to PG.

1

Next earnings PG reports in 65 days Oct 22

Against street estimates

How PG's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.

8 most recent of 9 quarters · newest report Jul 29 · projection Aug 17

Result
Jul 29 1.411.43+1.6%In line
Apr 24 1.561.59+2.2%Beat
Jan 22 1.861.88+1.3%In line
Oct 24 '25 1.901.99+4.9%Beat
Jul 29 '25 1.421.48+4.1%Beat
Apr 24 '25 1.531.54+0.9%In line
Jan 22 '25 1.861.88+1.1%In line
Oct 18 '24 1.901.93+1.8%In line

News (last pull)

Headlines about PG from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.

pulled 35 days ago · Jul 14